Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee manufacturers will shift production to the U.S.
<iframe src="https://statesidedaily.com/embed/cluster/f7115e707647ea325ded683d1f0ddc3e351fb528" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="What Trump's generic drug tariffs could mean, according to experts"></iframe>
Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee manufacturers will shift production to the U.S.
